|
"陳昆鋒"的相關文件
顯示項目 11-30 / 30 (共1頁)
1
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2014 |
CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation
|
Wang, Cheng-Yi; Chao, Ting-Ting; Chang, Fang-Yu; Chen, Yen-Lin; Tsai, Yi-Ting; Lin, Hen-I; Huang, Yuh-Chin T.; Shiau, Chung-Wai; Yu, Chong-Jen; Chen, Kuen-Feng; 余忠仁; 陳昆鋒 |
| 國立臺灣大學 |
2014 |
TD-19, an Erlotinib Derivative, Induces Epidermal Growth Factor Receptor Wild-Type Nonsmall-Cell Lung Cancer Apoptosis through CIP2A-Mediated Pathway
|
Chao, Ting-Ting; Wang, Cheng-Yi; Lai, Chih-Cheng; Chen, Yen-Lin; Tsai, Yi-Ting; Chen, Pao-Tzu; Lin, Hen-I; Huang, Yuh-Chin T.; Shiau, Chung-Wai; Yu, Chong-Jen; Chen, Kuen-Feng; 余忠仁; 陳昆鋒 |
| 國立臺灣大學 |
2014 |
Development of GADD45 beta (growth arrest DNA damage-inducible gene 45 beta) agonists for the treatment of hepatocellular carcinoma (HCC)
|
Hsu, Chiun; Ou, Da-Liang; Chen, Kuen-Feng; Lin, Zhong-Zhe; Cheng, Ann-Lii; Shiau, Chung-Wai; 林宗哲; 鄭安理; 許駿; 陳昆鋒; 歐大諒 |
| 國立臺灣大學 |
2012 |
CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells
|
Lin, Yu-Chin; Chen, Kuei-Chiu; Chen, Ching-Chow; Cheng, Ann-Lii; Chen, Kuen-Feng; 鄭安理; 陳昆鋒; 陳青周 |
| 國立臺灣大學 |
2012 |
Activation of tyrosine phosphatase SHP-1 determines the apoptotic effect of sorafenib on HCC cells.
|
Tai, W-T.; Shiau, C-W.; Cheng, A-L.; Chen, P-J.; Chen, K-F.; 陳昆鋒; 陳培哲 |
| 國立臺灣大學 |
2012 |
Novel sorafenib derivatives (SC-40, SC-43 and SC-60) show better anti-tumor effects than sorafenib in hepatocellular carcinoma through SHP-1/STAT3-mediated signaling pathway
|
Tai, Wei-Tien; Shiau, Chung-Wai; Cheng, Ann-Lii; Chen, Pel-Jer; Chen, Kuen-Feng; 鄭安理; 陳昆鋒; 陳培哲 |
| 國立臺灣大學 |
2012 |
Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity
|
Chen, Kuen-Feng; Tai, Wei-Tien; Hsu, Cheng-Yi; Huang, Jui-Wen; Liu, Chun-Yu; Chen, Pei-Jer; Kim, InKi; Shiau, Chung-Wai; 陳昆鋒; 陳培哲 |
| 國立臺灣大學 |
2012 |
Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists
|
Su, Jung-Chen; Chen, Kuen-Feng; Chen, Wei-Lin; Liu, Chun-Yu; Huang, Jui-Wen; Tai, Wei-Tien; Chen, Pei-Jer; Kim, Inki; Shiau, Chung-Wai; 陳昆鋒; 陳培哲 |
| 國立臺灣大學 |
2010 |
Cip2a Mediates Effects of Bortezomib on Phospho-Akt and Apoptosis in Hepatocellular Carcinoma Cells
|
陳昆鋒; 林育靖; 陳培哲; 鄭安理; CHEN, KUEN-FENG; LIN, YU-CHIN; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Sorafenib Overcomes Trail Resistance of Hepatocellular Carcinoma Cells through the Inhibition of Stat3
|
陳昆鋒; 黃祥博; 林育靖; 蕭崇瑋; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HUANG, HSIANG-PO; LIN, YU-CHIN; SHIAU, CHUNG-WAI; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Synergistic Interactions between Sorafenib and Bortezomib in Hepatocellular Carcinoma Involve Pp2a-Dependent Akt Inactivation
|
陳昆鋒; 李水盛; 陳培哲; 鄭安理; CHEN, KUEN-FENG; LEE, SHOEI-SHENG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Induction of DNA Damage-Inducible Gene Gadd45 Beta Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells
|
歐大諒; 沈盈君; 俞松良; 陳昆鋒; 葉培彥; 林亮音; 許駿; 鄭安理; OU DA-LIANG; SHEN YING-CHUN; YU SUNG-LIANG; CHEN KUEN-FENG; YEH PEI-YEN; LIN LIANG-IN; HSU CHIUN; CHENG ANN-LII |
| 國立臺灣大學 |
2009 |
Sorafenib Overcomes Trail Resistance of Hepatocellular Carcinoma Cells through the Inhibition of Signal Transducers and Activators of Transcription 3
|
陳昆鋒; 戴瑋恬; 陳培哲; 鄭安理; CHEN, KUEN-FENG; TAI, WEI-TIEN; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2008-07-31 |
以組蛋白去乙醯化酉每抑制劑為肝癌新治療的可行性研究
|
陳昆鋒 |
| 國立臺灣大學 |
2008 |
Osu-03012, a Novel Celecoxib Derivative, Induces Reactive Oxygen Species- Related Autophagy in Hepatocellular Carcinoma
|
高明; 葉培彥; 盧彥伸; 徐志宏; 陳昆鋒; 陳慶士; 郭明良; 鄭安理; GAO, MING; YEH, PEI-YEN; LU, YEN-SHEN; HSU, CHIH-HUNG; CHEN, KUEN-FENG; CHEN, CHING-SHIH; KUO, MIN-LIANG; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Sorafenib Overcomes Bortezomib Resistance of Hepatocellular Carcinoma Cells by down-Regulating Phospho-Akt and Bcl-2
|
陳昆鋒; 許駿; 徐志宏; 葉培彥; 李水盛; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HSU, CHIUN; HSU, CHIH-HUNG; YEH, PEI-YEN; LEE, SHOEI-SHENG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Down-Regulation of Phospho-Akt Is a Major Molecular Determinant of Bortezomib-Induced Apoptosis in Hepatocellular Carcinoma Cells
|
陳昆鋒; 葉培彥; 葉坤輝; 盧彥伸; 黃聖懿; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; YEH, KUN-HUEI; LU, YEN-SHEN; HUANG, SHANG-YI; CHENG, ANN-LII |
| 國立臺灣大學 |
1999 |
New Perspectives on the Management of Low Levels of High-Density Lipoprotein Cholesterol
|
陳昆鋒; 陳晶瑩; CHEN, CHIN-YING |
顯示項目 11-30 / 30 (共1頁)
1
每頁顯示[10|25|50]項目
|
